Anticancer Effects of Arsenic Compounds in Non-Small Cell Lung Cancer
Journal Title: Diseases & Research - Year 2024, Vol 4, Issue 2
Abstract
Non-small cell lung cancer (NSCLC) is the most common and prevalent subtype of lung cancer and continues to be one of the leading causes of cancer-related deaths worldwide. Despite various treatment options, a majority of NSCLC patients continue to experience disease progression and associated side effects, which are largely attributed to drug resistance, indicating the need for alternative strategies to combat this deadly disease. Among various applicable alternative approaches, repurposed drugs such as arsenic compounds have been shown to exert anticarcinogenic properties against NSCLC and possess the ability to overcome drug resistance mechanisms. Notably, numerous studies have demonstrated that the antitumor effects of arsenic compounds such as arsenic trioxide, arsenic sulfide, and tetra arsenic hexoxide are mediated via their ability to target several oncogenic signaling pathways, including nuclear factor-kappa B (NF-kB), epidermal growth factor receptor (EGFR), and signal transducer and activator of transcription 3 (STAT3). Inhibition of such signaling cascades results in altered cellular activities, including cell cycle arrest, decreased proliferation, and increased apoptosis. Importantly, these arsenic compounds have also been shown to overcome tumor resistance mechanisms and/or exert synergy in combination with other therapeutic agents resulting in the augmentation of cancer cell cytotoxicity. This review highlights the anticarcinogenic mechanisms of arsenic compounds and their impact on the efficacy of therapeutic agents.
Authors and Affiliations
Neelima Konduri, Anita Thyagarajan , Ravi P. Sahu
Keywords
Related Articles
- EP ID EP764975
- DOI 10.54457/DR.202402003
- Views 14
- Downloads 0
Characteristics of Patients with Cryptogenic Cirrhosis: A Retrospective Study
Backgrounds This study aimed to achieve a better understanding of the characteristics of patients with cryptogenic cirrhosis (CC). Methods We retrospectively enrolled 50 patients with CC between January 2018 and Decembe...
Roles of Toll-like Receptor 3 in Intrauterine Transmission of Hepatitis B Virus in Mothers with High Viral Load
Backgrounds Despite passive and active immunization, perinatal mother-to-infant transmission (MTIT) of hepatitis B virus (HBV) still occurs in women with high levels of viremia. Thus, understanding the mechanisms of MTIT...
Gut Microbiota is A Crucial Bridge Mediating the Pharmacological Effect of Labiatae Traditional Chinese Medicine
Labiatae, a family of the dicotyledonous plants, has attracted extensive interest because of its wide application in foods, drugs and cosmetics. According to the National Census of Chinese Medicine Resources, Labiatae co...
Angioimmunoblastic T Cell Lymphoma Complicated by Cirrhosis Decompensation
A 55-year-old male with a history of hepatitis B was hospitalized for persistent cough, fever, rash, and abdominal bloating. Despite treatment for suspected respiratory infection with multiple antibiotics, his symptoms w...
Clinical Progress of Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Concurrent chemoradiotherapy (CCRT) is the foundational standard-of-care for patients with locoregionally advanced nasopharyngeal carcinoma (LANPC). Adding adjuvant chemotherapy (AC) or induction chemotherapy (IC) to CCR...